
Vaxxas completes enrolment in Phase I H7N9 bird flu vaccine trial
Australian-American biotech Vaxxas has announced the completion of enrolment for its Phase I avian influenza A (H7N9) vaccine, which is delivered through a microneedle patch applied to the skin. The company has successfully enrolled 258 healthy volunteers …